Annual sales were KRW 5.75 billion in 2022, KRW 5.2 billion in 2023 (down 9.7% year on year) and KRW 4.87 billion in 2024 (down 6.3%), before jumping to KRW 27 billion in 2025 (up 453.3%). Among 2022 to 2025, 2025 was the largest year and 2024 the smallest.
Cosmetics sales, which did not exist until 2024, exceeded KRW 12 billion in 2025 and drove the increase, according to the company.
Operating losses were KRW 12.9 billion in 2022, KRW 12.7 billion in 2023, KRW 13.3 billion in 2024 and KRW 9.05 billion in 2025, and the operating margin moved from -224.1% in 2022 to -33.6% in 2025.
Net loss attributable to controlling shareholders was KRW 10.3 billion in 2022, KRW 13.4 billion in 2023 (loss widened year on year), KRW 7.68 billion in 2024 (loss narrowed) and KRW 32 billion in 2025 (loss widened).
In 2025 the net loss was far larger than the operating loss, and the net loss including non-controlling interests was the same KRW 32 billion. The debt-to-equity ratio rose from 93.4% in 2022 to 220.0% in 2023 and 306.6% in 2024 before easing to 255.6% in 2025.
At end-2025 total equity was KRW 26.1 billion, all of it attributable to controlling shareholders, against total liabilities of KRW 66.6 billion. Operating cash flow was -KRW 5.89 billion in 2022, -KRW 6.96 billion in 2023, -KRW 11.7 billion in 2024 and -KRW 7.47 billion in 2025, negative in every year.
Quarterly sales rose from KRW 6.95 billion in Q3 2025 to KRW 7.52 billion in Q4 2025 (up 8.2% quarter on quarter), KRW 8.72 billion in Q1 2026 (up 16.0%) and KRW 9.54 billion in Q2 2026 (up 9.3%). Q3 2026 sales of KRW 8.89 billion fell 6.7% from the prior quarter but rose 27.9% from a year earlier.
Operating results moved from an operating loss of KRW 1.26 billion in Q3 2025 and KRW 2.29 billion in Q4 2025 to losses of KRW 931 million in Q1 2026 and KRW 928 million in Q2 2026, and then to an operating profit of KRW 136 million in Q3 2026.
The company attributed the profit turn to economies of scale from mass production of freeze-dried ball cosmetics and to lower losses in the production process. Cost of sales as a share of revenue was 61.7% in the quarter, below the prior-year level.
Net loss attributable to controlling shareholders narrowed to KRW 1.52 billion in Q3 2026, but the four-quarter total from Q4 2025 to Q3 2026 is KRW 23.6 billion. Cumulative sales for January to September 2026 were KRW 27.17 billion, up 39.7%, according to the provisional disclosure of October 19, 2026.